Position in BMY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,501,922
-$55,447 QoQ
Shares Held
26,066
+1.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#953
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 72%
Shared 27%
None 1%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PEOPLES FINANCIAL SERVICES CORP. holds $30,501,464 across 11 Drug Manufacturers - General names. BMY ranks #6 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,244 | $13,486,391 | |
| 2 | JNJ |
Johnson & Johnson
|
19,251 | $4,889,175 | |
| 3 | ABBV |
AbbVie Inc.
|
18,482 | $4,650,810 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,170 | $2,848,845 | |
| 5 | AMGN |
Amgen Inc
|
4,453 | $1,612,520 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
26,066 | $1,501,922 | |
| 7 | PFE |
Pfizer Inc
|
36,641 | $882,314 | |
| 8 | NVS |
Novartis AG
|
1,703 | $266,893 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,501,922 | 26,066 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,557,369 | 25,678 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,022,270 | 18,952 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $896,226 | 19,872 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $932,789 | 20,151 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,229,008 | 20,151 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,143,982 | 20,226 | Shares | Defined | 2025-01-14 | |
| 2024-09-30 | $1,059,686 | 20,481 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $925,412 | 22,283 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,226,356 | 22,614 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $1,581,630 | 30,825 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $1,887,634 | 32,523 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $2,097,112 | 32,793 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $2,354,668 | 33,973 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $2,536,956 | 35,260 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $2,609,358 | 36,705 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $2,841,069 | 36,897 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $2,713,721 | 37,159 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $2,454,032 | 39,359 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $2,551,942 | 43,129 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $2,935,602 | 43,933 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $2,835,041 | 44,908 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $2,829,684 | 45,618 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $2,763,873 | 45,843 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $2,701,448 | 45,943 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $2,558,354 | 45,898 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||